Literature DB >> 12589922

BDNF: a neuromodulator in nociceptive pathways?

Sophie Pezet1, Marzia Malcangio, Stephen B McMahon.   

Abstract

During development, brain-derived neurotrophic factor (BDNF) supports the survival of certain neuronal population in central and peripheral nervous system. In adulthood, BDNF has been suggested to act as an important modulator of synaptic plasticity. This article reviews and discusses its potential role as neuromodulator in the spinal dorsal horn. BDNF is synthesized in the cell body of primary sensory neurons (pre-synaptic neurons) and its expression is regulated in models of inflammatory and neuropathic pain. The high affinity receptor for BDNF, tropomyosine receptor kinase B (TrkB), is expressed by post-synaptic neurons of the dorsal horn. Stimulation of pre-synaptic nociceptive afferent fibres induces BDNF release and consequent activation of TrkB receptors leading to a post-synaptic excitability. Electrophysiological recordings showed that BDNF enhances the ventral root potential induced by C-fibre stimulation in an in vitro preparation. In addition, behavioural data indicate that antagonism of BDNF attenuates the second phase of hyperalgesia induced by formalin (in nerve growth factor-treated animals) and the thermal hyperalgesia induced by carageenan, suggesting that BDNF is involved in some aspects of central sensitisation in conditions of peripheral inflammation. In conclusion, BDNF meets many of the criteria necessary to define it as a neurotransmitter/neuromodulator in small diameter nociceptive neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12589922     DOI: 10.1016/s0165-0173(02)00206-0

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  52 in total

Review 1.  The discovery and development of analgesics: new mechanisms, new modalities.

Authors:  Gillian Burgess; Dic Williams
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

2.  Quantitative analysis of BDNF/TrkB protein and mRNA in cortical and striatal neurons using α-tubulin as a normalization factor.

Authors:  Bin Ma; Jeffrey N Savas; Moses V Chao; Naoko Tanese
Journal:  Cytometry A       Date:  2012-05-30       Impact factor: 4.355

3.  TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury.

Authors:  Koichi Obata; Hirokazu Katsura; Toshiyuki Mizushima; Hiroki Yamanaka; Kimiko Kobayashi; Yi Dai; Tetsuo Fukuoka; Atsushi Tokunaga; Makoto Tominaga; Koichi Noguchi
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

4.  Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation.

Authors:  Wei Guo; Meredith T Robbins; Feng Wei; Shiping Zou; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 5.  [Peripheral mechanisms of joint pain with special focus on the synovial fibroblast].

Authors:  H Sprott
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

6.  Intense training overcomes effects of the Val66Met BDNF polymorphism on short-term plasticity.

Authors:  Stephanie A McHughen; Kristin Pearson-Fuhrhop; Vivian K Ngo; Steven C Cramer
Journal:  Exp Brain Res       Date:  2011-07-17       Impact factor: 1.972

Review 7.  Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative.

Authors:  Cory J Xian; Xin-Fu Zhou
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

Review 8.  Estrogen and chronic daily headache.

Authors:  Dawn A Marcus
Journal:  Curr Pain Headache Rep       Date:  2004-02

Review 9.  Neurotrophins as regulators of urinary bladder function.

Authors:  Peter Ochodnicky; Célia D Cruz; Naoki Yoshimura; Francisco Cruz
Journal:  Nat Rev Urol       Date:  2012-10-09       Impact factor: 14.432

10.  TrkB signaling is required for both the induction and maintenance of tissue and nerve injury-induced persistent pain.

Authors:  Xidao Wang; Joseline Ratnam; Bende Zou; Pamela M England; Allan I Basbaum
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.